Adagene

Adagene EBITDA per Share

The EBITDA per Share of Adagene (ADAG) as of Oct 16, 2026 is -0.36 USD. In the previous year, EBITDA per Share was -0.98 USD — a change of -63.04% (higher).

EBITDA per Share

-0.36USD

YoY

-63.04%

Last updated:

EBITDA per Share of Adagene is 2025 -0.36 USD. EBITDA per Share of Adagene was 2024 -0.98 USD. It decreases by -63.04% higher compared to the previous year.

The Adagene EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-1.79 USD
Jan 1, 2019
-0.70 USD
Jan 1, 2020
-0.45 USD
Jan 1, 2021
-1.33 USD
Jan 1, 2022
-1.55 USD
Jan 1, 2023
-0.68 USD
Jan 1, 2024
-0.98 USD
Jan 1, 2025
-0.36 USD
The Adagene EBITDA per Share history
YEAREBITDA per ShareYoY
-0.36USD-63.04%
-0.98USD+44.98%
-0.68USD-56.48%
-1.55USD+17.11%
-1.33USD+191.65%
-0.45USD-34.74%
-0.70USD-61.01%
-1.79USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adagene Stock analysis

What does Adagene do? Adagene Inc., based in Suzhou, China, is a clinical-stage biotechnology company focused on developing monoclonal antibody drugs for cancer treatment. The company operates in the Health Care sector, with its lead candidates ADG126 and ADG116 in phase 1b/2 trials for various cancers, alongside other pipeline products in clinical and preclinical stages. Listed on 9 February 2021, Adagene employs 128 people and is dedicated to advancing innovative therapies for solid tumors and hematologic malignancies. Adagene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adagene stock

EBITDA per Share of Adagene is -0.36 USD in 2025.

EBITDA per Share of Adagene changed from -0.98 USD to -0.36 USD, representing a -63.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Adagene since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Adagene

All Key Metrics — Adagene